Visual impairment is associated with deficits in cognitive function and risk for cognitive decline and Alzheimer’s disease (AD).
Objective:
The purpose of this study was to characterize the degree of visual impairment and explore the association thereof with cortical atrophy in brain regions associated with visual processing in individuals with (or at risk for) AD.
Methods:
Using the Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) dataset, we analyzed vision and brain imaging data from three diagnostic groups: individuals with subjective cognitive decline (SCD; N = 35), mild cognitive impairment (MCI; N = 74), and mild AD (N = 30). We used ANCOVAs to determine whether performance on reading acuity and contrast sensitivity tests differed across diagnostic groups. Hierarchical regression analyses were applied to determine whether visual performance predicted gray matter volume for vision-related regions of interest above and beyond group membership.
Results:
The AD group performed significantly worse on reading acuity (F(2,138) = 4.12, p < 0.01, ω2 = 0.04) compared to the SCD group and on contrast sensitivity (F(2,138) = 7.6, p < 0.01, ω2 = 0.09) compared to the SCD and MCI groups, which did not differ from each other. Visual performance was associated with volume in some vision-related structures beyond clinical diagnosis.
Conclusion:
Our findings demonstrate poor visual performance in AD and that both group membership and visual performance are predictors of cortical pathology, consistent with the idea that atrophy in visual areas and pathways contributes to the functional vision deficits observed in AD.
HanJH, LeeHJ, JungJ, ParkE-C (2019) Effects of self-reported hearing or vision impairment on depressive symptoms: a population-based longitudinal study. Epidemiol Psychiatr Sci28, 343–355.
5.
HassellJB (2006) Impact of age related macular degeneration on quality of life. Br J Ophthalmol90, 593–596.
6.
HarwoodRH (2001) Visual problems and falls. Age Ageing30, 13–18.
7.
KulmalaJ, ViljanenA, SipilaS, PajalaS, ParssinenO, KauppinenM, KoskenvuoM, KaprioJ, RantanenT (2009) Poor vision accompanied with other sensory impairments as a predictor of falls in older women. Age Ageing38, 162–167.
SwenorBK, LeeMJ, TianJ, VaradarajV, Bandeen-RocheK (2020) Visual impairment and frailty: Examining an understudied relationship. J Gerontol75, 596–602.
10.
VuHTV (2005) Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol89, 360–363.
11.
YamadaY, VlachovaM, RichterT, Finne-SoveriH, GindinJ, van der RoestH, DenkingerMD, BernabeiR, OnderG, TopinkovaE (2014) Prevalence and correlates of hearing and visual impairments in European nursing homes: Results from the SHELTER study. J Am Med Dir Assoc15, 738–743.
12.
BowenM, EdgarDF, HancockB, HaqueS, ShahR, BuchananS, IliffeS, MaskellS, PickettJ, TaylorJ-P, O’LearyN (2016) The Prevalence of Visual Impairment in People with Dementia (the PrOVIDe study): a cross-sectional study of people aged 60-89 years with dementia and qualitative exploration of individual, carer and professional perspectives. Health Serv Deliv Res4, 1–200.
13.
WhitsonHE, CousinsSW, BurchettBM, HybelsCF, PieperCF, CohenHJ (2007) The combined effect of visual impairment and cognitive impairment on disability in older people: Effect of coexisting visual and cognitive impairment. J Am Geriatr Soc55, 885–891.
AlbersMW, GilmoreGC, KayeJ, MurphyC, WingfieldA, BennettDA, BoxerAL, BuchmanAS, CruickshanksKJ, DevanandDP, DuffyCJ, GallCM, GatesGA, GranholmA-C, HenschT, HoltzerR, HymanBT, LinFR, McKeeAC, MorrisJC, PetersenRC, SilbertLC, StrubleRG, TrojanowskiJQ, VergheseJ, WilsonDA, XuS, ZhangLI (2015) At the interface of sensory and motor dysfunctions and Alzheimer’s disease. Alzheimers Dement11, 70–98.
16.
GiroudN, Pichora-FullerMK, MickP, WittichW, Al-YawerF, RehanS, OrangeJB, PhillipsNA (2021) Hearing loss is associated with gray matter differences in older adults at risk for and with Alzheimer’s disease. Aging Brain1, 100018.
17.
LinMY, GutierrezPR, StoneKL, YaffeK, EnsrudKE, FinkHA, SarkisianCA, ColemanAL, MangioneCM (2004) Vision impairment and combined vision and hearing impairment predict cognitive and functional decline in older women: Sensory impairments predict cognitive and functional decline. J Am Geriatr Soc52, 1996–2002.
18.
AnsteyKJ, LuszczMA, SanchezL (2001) Two-year decline in vision but not hearing is associated with memory decline in very old adults in a population-based sample. Gerontology47, 289–293.
19.
SpiererO, FischerN, BarakA, BelkinM (2016) Correlation between vision and cognitive function in the elderly: A cross-sectional study. Medicine95, e2423.
20.
ChenSP, BhattacharyaJ, PershingS (2017) Association of vision loss with cognition in older adults. JAMA Ophthalmol135, 963.
21.
Reyes-OrtizCA, KuoY-F, DiNuzzoAR, RayLA, RajiMA, MarkidesKS (2005) Near vision impairment predicts cognitive decline: Data from the Hispanic Established Populations for Epidemiologic Studies of the Elderly. J Am Geriatr Soc53, 681–686.
22.
SwenorBK, WangJ, VaradarajV, RosanoC, YaffeK, AlbertM, SimonsickEM (2019) Vision impairment and cognitive outcomes in older adults: The Health ABC Study. J Gerontol74, 1454–1460.
23.
ZhengDD, SwenorBK, ChristSL, WestSK, LamBL, LeeDJ (2018) Longitudinal Associations between visual impairment and cognitive functioning: The Salisbury Eye Evaluation Study. JAMA Ophthalmol136, 989.
24.
ValentijnSAM, Van BoxtelMPJ, Van HoorenSAH, BosmaH, BeckersHJM, PondsRWHM, JollesJ (2005) Change in sensory functioning predicts change in cognitive functioning: Results from a 6-year follow-up in the Maastricht Aging Study. J Am Geriatr Soc53, 374–380.
25.
FischerME, CruickshanksKJ, SchubertCR, PintoAA, CarlssonCM, KleinBEK, KleinR, TweedTS (2016) Age-related sensory impairments and risk of cognitive impairment. J Am Geriatr Soc64, 1981–1987.
26.
Davies-KershawHR, HackettRA, CadarD, HerbertA, OrrellM, SteptoeA (2018) Vision impairment and risk of dementia: Findings from the English Longitudinal Study of Ageing. J Am Geriatr Soc66, 1823–1829.
27.
WardME, GelfandJM, LuiL-Y, OuY, GreenAJ, StoneK, PedulaKL, CummingsSR, YaffeK (2018) Reduced contrast sensitivity among older women is associated with increased risk of cognitive impairment: Reduced contrast sensitivity. Ann Neurol83, 730–738.
28.
NaëlV, PérèsK, DartiguesJ-F, LetenneurL, AmievaH, ArleoA, ScherlenA-C, TzourioC, BerrC, CarrièreI, DelcourtC, HelmerC (2019) Vision loss and 12-year risk of dementia in older adults: the 3C cohort study. Eur J Epidemiol34, 141–152.
29.
ElyashivSM, ShabtaiEL, BelkinM (2014) Correlation between visual acuity and cognitive functions. Br J Ophthalmol98, 129–132.
30.
RogersMAM, LangaKM (2010) Untreated poor vision: A contributing factor to late-life dementia. Am J Epidemiol171, 728–735.
31.
HajekA, BrettschneiderC, LühmannD, EiseleM, MamoneS, WieseB, WeyererS, WerleJ, PentzekM, FuchsA, Riedel-HellerSG, LuckT, BickelH, WeegD, KopparaA, WagnerM, SchererM, MaierW, KönigH-H, the Study on Ageing, Cognition and Dementia in Primary Care Patients Group (2016) Effect of visual impairment on physical and cognitive function in old age: Findings of a population-based prospective cohort study in Germany. J Am Geriatr Soc64, 2311–2316.
Cronin-GolombA, CorkinS, RizzoJF, CohenJ, GrowdonJH, BanksKS (1991) Visual dysfunction in Alzheimer’s disease: Relation to normal aging. Ann Neurol29, 41–52.
LindenbergerU, BaltesPB (1994) Sensory functioning and intelligence in old age: A strong connection. Psychol Aging9, 339–355.
50.
BaltesPB, LindenbergerU (1997) Emergence of a powerful connection between sensory and cognitive functions across the adult life span: A new window to the study of cognitive aging?Psychol Aging12, 12–21.
51.
WooSJ, ParkKH, AhnJ, ChoeJY, JeongH, HanJW, KimTH, KimKW (2012) Cognitive impairment in age-related macular degeneration and geographic atrophy. Ophthalmology119, 2094–2101.
52.
RongSS, LeeBY, KukAK, YuXT, LiSS, LiJ, GuoY, YinY, OsterburDL, YamJCS, CheungCY, ChenLJ, WongTY, NgDS-C (2019) Comorbidity of dementia and age-related macular degeneration calls for clinical awareness: A meta-analysis. Br J Ophthalmol103, 1777–1783.
53.
ChoiS, JahngWJ, ParkSM, JeeD (2020) Association of age-related macular degeneration on Alzheimer or Parkinson disease: A retrospective cohort study. Am J Ophthalmol210, 41–47.
54.
BayerAU, FerrariF, ErbC (2002) High occurrence rate of glaucoma among patients with Alzheimer’s disease. Eur Neurol47, 165–168.
55.
TamuraH, KawakamiH, KanamotoT, KatoT, YokoyamaT, SasakiK, IzumiY, MatsumotoM, MishimaHK (2006) High frequency of open-angle glaucoma in Japanese patients with Alzheimer’s disease. J Neurol Sci246, 79–83.
Ohno-MatsuiK (2011) Parallel findings in age-related macular degeneration and Alzheimer’s disease. Prog Retin Eye Res30, 217–238.
58.
JohnsonLV, LeitnerWP, RivestAJ, StaplesMK, RadekeMJ, AndersonDH (2002) The Alzheimer’s A-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A99, 11830–11835.
59.
IkramMK, CheungCY, WongTY, ChenCPLH (2012) Retinal pathology as biomarker for cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiat83, 917–922.
60.
KusneY, WolfAB, TownleyK, ConwayM, PeymanGA (2017) Visual system manifestations of Alzheimer’s disease. Acta Ophthalmol95, e668–e676.
61.
ValentiDA (2010) Alzheimer’s disease and glaucoma: Imaging the biomarkers of neurodegenerative disease. Int J Alzheimers Dis2010, 793931.
62.
BamboMP, Garcia-MartinE, PinillaJ, HerreroR, SatueM, OtinS, FuertesI, MarquesML, PabloLE (2014) Detection of retinal nerve fiber layer degeneration in patients with Alzheimer’s disease using optical coherence tomography: Searching new biomarkers. Acta Ophthalmol92, e581–e582.
63.
LuY, LiZ, ZhangX, MingB, JiaJ, WangR, MaD (2010) Retinal nerve fiber layer structure abnormalities in early Alzheimer’s disease: Evidence in optical coherence tomography. Neurosci Lett480, 69–72.
64.
KirbasS, TurkyilmazK, AnlarO, TufekciA, DurmusM (2013) Retinal nerve fiber layer thickness in patients with Alzheimer disease:J Neuroophthalmol33, 58–61.
65.
HintonDR, SadunAA, BlanksJC, MillerCA (1986) Optic-nerve degeneration in Alzheimer’s disease. N Engl J Med315, 485–487.
66.
JorgeL, CanárioN, QuentalH, BernardesR, Castelo-BrancoM (2020) Is the retina a mirror of the aging brain? Aging of neural retina layers and primary visual cortex across the Lifespan. Front Aging Neurosci11, 360.
67.
SalatDH (2004) Thinning of the cerebral cortex in aging. Cereb Cortex14, 721–730.
McGinnisSM, BrickhouseM, PascualB, DickersonBC (2011) Age-related changes in the thickness of cortical zones in humans. Brain Topogr24, 279–291.
70.
ThambisettyM, WanJ, CarassA, AnY, PrinceJL, ResnickSM (2010) Longitudinal changes in cortical thickness associated with normal aging. Neuroimage52, 1215–1223.
71.
LemaitreH, GoldmanAL, SambataroF, VerchinskiBA, Meyer-LindenbergA, WeinbergerDR, MattayVS (2012) Normal age-related brain morphometric changes: Nonuniformity across cortical thickness, surface area and gray matter volume?Neurobiol Aging33, 617.e1–617.e9.
72.
Cronin-GolombA, RizzoJF, CorkinS, GrowdonJH (1991) Visual function in Alzheimer’s disease and normal aging. Ann N Y Acad Sci640, 28–35.
73.
BoucardCC, HernowoAT, MaguireRP, JansoniusNM, RoerdinkJBTM, HooymansJMM, CornelissenFW (2009) Changes in cortical grey matter density associated with long-standing retinal visual field defects. Brain132, 1898–1906.
74.
BurgeWK, GriffisJC, NenertR, ElkhetaliA, DeCarloDK, ver HoefLW, RossLA, VisscherKM (2016) Cortical thickness in human V1 associated with central vision loss. Sci Rep6, 23268.
75.
PlankT, FroloJ, Brandl-RühleS, RennerAB, HufendiekK, HelbigH, GreenleeMW (2011) Gray matter alterations in visual cortex of patients with loss of central vision due to hereditary retinal dystrophies. Neuroimage56, 1556–1565.
76.
PrinsD, HanekampS, CornelissenFW (2016) Structural brain MRI studies in eye diseases: Are they clinically relevant? A review of current findings. Acta Ophthalmol94, 113–121.
77.
HernowoAT, PrinsD, BaselerHA, PlankT, GouwsAD, HooymansJMM, MorlandAB, GreenleeMW, CornelissenFW (2014) Morphometric analyses of the visual pathways in macular degeneration. Cortex56, 99–110.
78.
ChenWW, WangN, CaiS, FangZ, YuM, WuQ, TangL, GuoB, FengY, JonasJB, ChenX, LiuX, GongQ (2013) Structural brain abnormalities in patients with primary open-angle glaucoma: A study with 3T MR imaging. Invest Ophthalmol Vis Sci54, 545.
79.
DuncanRO, BoyntonGM (2003) Cortical magnification within human primary visual cortex correlates with acuity thresholds. Neuron38, 659–671.
80.
AvidanG, HarelM, HendlerT, Ben-BashatD, ZoharyE, MalachR (2002) Contrast sensitivity in human visual areas and its relationship to object recognition. J Neurophysiol87, 3102–3116.
81.
DickersonBC, BakkourA, SalatDH, FeczkoE, PachecoJ, GreveDN, GrodsteinF, WrightCI, BlackerD, RosasHD, SperlingRA, AtriA, GrowdonJH, HymanBT, MorrisJC, FischlB, BucknerRL (2009) The cortical signature of Alzheimer’s disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex19, 497–510.
82.
KiuchiK, KitamuraS, TaokaT, YasunoF, TanimuraM, MatsuokaK, IkawaD, ToritsukaM, HashimotoK, MakinodanM, KosakaJ, MorikawaM, KichikawaK, KishimotoT (2014) Gray and white matter changes in subjective cognitive impairment, amnestic mild cognitive impairment and Alzheimer’s disease: A voxel-based analysis Study. PLoS One9, 104007.
ChertkowH, BorrieM, WhiteheadV, BlackSE, FeldmanHH, GauthierS, HoganDB, MasellisM, McGiltonK, RockwoodK, TierneyMC, AndrewM, HsiungG-YR, CamicioliR, SmithEE, FogartyJ, LindsayJ, BestS, EvansA, DasS, MohaddesZ, PilonR, PoirierJ, PhillipsNA, MacNamaraE, DixonRA, DuchesneS, MacKenzieI, RylettRJ (2019) The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study. Can J Neurol Sci46, 499–511.
85.
NasreddineZS, PhillipsNA, BédirianV, CharbonneauS, WhiteheadV, CollinI, CummingsJL, ChertkowH (2005) The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc53, 695–699.
86.
DasS, ZijdenbosAP, HarlapJ, VinsD, EvansAC (2012) LORIS: A web-based data management system for multi-center studies. Front Neuroinform5, 37.
87.
MohaddesZ, DasS, Abou-HaidarR, Safi-HarabM, BladerD, CallegaroJ, Henri-BellemareC, TuntengJ-F, EvansL, CampbellT, LoD, MorinP-E, WhiteheadV, ChertkowH, EvansAC (2018) National Neuroinformatics Framework for Canadian Consortium on Neurodegeneration in Aging (CCNA). Front Neuroinform12, 85.
88.
JessenF, AmariglioRE, van BoxtelM, BretelerM, CeccaldiM, ChételatG, DuboisB, DufouilC, EllisKA, van der FlierWM, GlodzikL, van HartenAC, de LeonMJ, McHughP, MielkeMM, MolinuevoJL, MosconiL, OsorioRS, PerrotinA, PetersenRC, RabinLA, RamiL, ReisbergB, RentzDM, SachdevPS, de la SayetteV, SaykinAJ, ScheltensP, ShulmanMB, SlavinMJ, SperlingRA, StewartR, UspenskayaO, VellasB, VisserPJ, WagnerM, Subjective Cognitive Decline Initiative (SCD-I) Working Group (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement10, 844–852.
89.
JessenF, AmariglioRE, BuckleyRF, van der FlierWM, HanY, MolinuevoJL, RabinL, RentzDM, Rodriguez-GomezO, SaykinAJ, SikkesSAM, SmartCM, WolfsgruberS, WagnerM (2020) The characterisation of subjective cognitive decline. Lancet Neurol19, 271–278.
90.
MorrisJC, HeymanA, MohsRC, HughesJP, van BelleG, FillenbaumG, MellitsED, ClarkC (1989) The consortium to establish a registry for Alzheimer’s disease (CERAD): I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology39, 1159–1165.
91.
CheluneGJ, BornsteinRA, PrifiteraA (1990) The Wechsler Memory Scale—Revised. In Advances in Psychological Assessment: Volume 7, McReynolds P, Rosen JC, Chelune GJ, eds. SpringerUS, Boston, MA, pp. 65–99.
92.
HughesCP, BergL, DanzigerW, CobenLA, MartinRL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry140, 566–572.
93.
AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, GamstA, HoltzmanDM, JagustWJ, PetersenRC, SnyderPJ, CarrilloMC, ThiesB, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 270–279.
94.
MansfieldJSAhnSJLeggeGE, LeubkerA (1993) A new reading-acuity chart for normal and low vision. Opt Soc Am Techn Digest3, 232–235.
95.
DoughertyBE, FlomRE, BullimoreMA (2005) An evaluation of the Mars Letter Contrast Sensitivity Test. Optom Vis Sci82, 970–975.
Mars Perceptrix (2020) The MARS Letter Contrast Sensitivity Test User Manual.
98.
DuchesneS, ChouinardI, PotvinO, FonovVS, KhademiA, BarthaR, BellecP, CollinsDL, DescoteauxM, HogeR, McCrearyCR, RamirezJ, ScottCJM, SmithEE, StrotherSC, BlackSE, for the CIMA-Q group and the CCNA group (2019) The Canadian Dementia Imaging Protocol: Harmonizing National Cohorts. J Magn Reson Imaging49, 456–465.
99.
FischlB, DaleAM (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A97, 11050–11055.
100.
FischlB (2004) Automatically parcellating the human cerebral cortex. Cereb Cortex14, 11–22.
101.
SherifT, RiouxP, RousseauM-E, KassisN, BeckN, AdalatR, DasS, GlatardT, EvansAC (2014) CBRAIN: A web-based, distributed computing platform for collaborative neuroimaging research. Front Neuroinform8, 54.
CollinsDL, PruessnerJC (2010) Towards accurate, automatic segmentation of the hippocampus and amygdala from MRI by augmenting ANIMAL with a template library and label fusion. Neuroimage52, 1355–1366.
104.
DestrieuxC, FischlB, DaleA, HalgrenE (2010) Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature. Neuroimage53, 1–15.
105.
MalikovicA, VuceticB, MilisavljevicM, TosevskiJ, SazdanovicP, MilojevicB, MalobabicS (2012) Occipital sulci of the human brain:Variability and morphometry. Anat Sci Int87, 61–70.
106.
WichmannW, Müller-ForellW (2004) Anatomy of the visual system. Eur J Radiol49, 8–30.
107.
WhitwellJL (2010) Progression of atrophy in Alzheimer’s disease and related disorders. Neurotox Res18, 339–346.
108.
WhitwellJL, PrzybelskiSA, WeigandSD, KnopmanDS, BoeveBF, PetersenRC, JackCR (2007) 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer’s disease. Brain130, 1777–1786.
109.
FoxNC, CrumWR, ScahillRI, StevensJM, JanssenJC, RossorMN (2001) Imaging of onset and progression of Alzheimer’s disease with voxel-compression mapping of serial magnetic resonance images. Lancet358, 201–205.
110.
BaronJC, ChételatG, DesgrangesB, PercheyG, LandeauB, de la SayetteV, EustacheF (2001) mapping of gray matter loss with voxel-based morphometry in mild Alzheimer’s disease. Neuroimage14, 298–309.
111.
MannDMA (1991) The topographic distribution of brain atrophy in Alzheimer’s disease. Acta Neuropathol83, 81–86.
112.
VoevodskayaO, SimmonsA, NordenskjöldR, KullbergJ, AhlströmH, LindL, WahlundL-O, LarssonE-M, WestmanE, Alzheimer’s Disease Neuroimaging Initiative (2014) The effects of intracranial volume adjustment approaches on multiple regional MRI volumes in healthy aging and Alzheimer’s disease. Front Aging Neurosci6, 264.
113.
WagenmakersE-J, FarrellS (2004) AIC model selection using Akaike weights. Psychon Bull Rev11, 192–196.
114.
MoutonPR, MartinLJ, CalhounME, Dal FornoG, PriceDL (1998) Cognitive decline strongly correlates with cortical atrophy in Alzheimer’s dementia. Neurobiol Aging19, 371–377.
115.
ObaraK, MeyerJS, MortelKF, MuramatsuK (1994) Cognitive declines correlate with decreased cortical volume and perfusion in dementia of Alzheimer type. J Neurol Sci127, 96–102.
116.
BrewerAA, BartonB (2014) Visual cortex in aging and Alzheimer’s disease: Changes in visual field maps and population receptive fields. Front Psychol5, 96–102.
117.
LewisD, CampbellM, TerryR, MorrisonJ (1987) Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer’s disease: A quantitative study of visual and auditory cortices. J Neurosci7, 1799–1808.
ArmstrongR (1996) Visual field defects in Alzheimer’s disease patients may reflect differential pathology in the primary visual cortex. Optom Vis Sci73, 677–682.
120.
Armstrong,R, Nocklin,D, Sumi,S.M., Alvord,J. (1990) Neuropathological changes in the visual cortex in Alzheimer’s disease. Neurosci Res Commun6, 163–171.
121.
LeubaG, SainiK (1995) Pathology of subcortical visual centres in relation to cortical degeneration in Alzheimer’s disease. Neuropathol Appl Neurobiol21, 410–422.
122.
BerishaF, FekeGT, TrempeCL, McMeelJW, SchepensCL (2007) Retinal abnormalities in early Alzheimer’s disease. Invest Ophthalmol Vis Sci48, 2285.
123.
Danesh-MeyerHV, BirchH, KuJY-F, CarrollS, GambleG (2006) Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology67, 1852–1854.
124.
CaillaudM, HudonC, BollerB, BrambatiS, DuchesneS, LorrainD, GagnonJ-F, MaltezosS, MellahS, PhillipsN, Consortium for the Early Identification of Alzheimer’s Disease-Quebec, Belleville S (2020) Evidence of a relation between hippocampal volume, white matter hyperintensities, and cognition in subjective cognitive decline and mild cognitive impairment. J Gerontol75, 1382–1392.
125.
BraakH, BraakE (1998) Evolution of neuronal changes in the course of Alzheimer’s disease. In Ageing and Dementia, JellingerK, FazekasF, WindischM, eds. Springer Vienna, Vienna, pp. 127–140.
126.
VorobyevVA, AlhoK, MedvedevSV, PakhomovSV, RoudasMS, RutkovskayaJM, TervaniemiM, van ZuijenTL, NäätänenR (2004) Linguistic processing in visual and modality-nonspecific brain areas: PET recordings during selective attention. Cogn Brain Res20, 309–322.
BassiCJ, SolomonK, YoungD (1993) Vision in aging and dementia. Optom Vis Sci70, 809–813.
131.
BejaninA, SchonhautDR, La JoieR, KramerJH, BakerSL, SosaN, AyaktaN, CantwellA, JanabiM, LauriolaM, O’NeilJP, Gorno-TempiniML, MillerZA, RosenHJ, MillerBL, JagustWJ, RabinoviciGD (2017) Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease. Brain140, 3286–3300.
132.
ChetelatG, VillemagneVL, VillainN, JonesG, EllisKA, AmesD, MartinsRN, MastersCL, RoweCC, on behalf of the AIBL Research Group (2012) Accelerated cortical atrophy in cognitively normal elderly with high -amyloid deposition. Neurology78, 477–484.
133.
BaumLW (2005) Sex, hormones, and Alzheimer’s disease. J Gerontol60, 736–743.
134.
IsekiE, MatsushitaM, KosakaK, KondoH, IshiiT, AmanoN (1989) Distribution and morphology of brain stem plaques in Alzheimer’s disease. Acta Neuropathol78, 131–136.
135.
VanegasMI, BlangeroA, GalvinJE, Di RoccoA, QuartaroneA, GhilardiMF, KellySP (2019) Altered dynamics of visual contextual interactions in Parkinson’s disease. NPJ Parkinsons Dis5, 13.
